GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (OTCPK:ALIOF) » Definitions » Cash Ratio

Actelion (Actelion) Cash Ratio : 1.45 (As of Mar. 2017)


View and export this data going back to . Start your Free Trial

What is Actelion Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Actelion's Cash Ratio for the quarter that ended in Mar. 2017 was 1.45.

Actelion has a Cash Ratio of 1.45. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Actelion's Cash Ratio or its related term are showing as below:

ALIOF's Cash Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.9
* Ranked among companies with meaningful Cash Ratio only.

Actelion Cash Ratio Historical Data

The historical data trend for Actelion's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Cash Ratio Chart

Actelion Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.44 0.90 1.81 0.96 0.87

Actelion Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.11 0.90 0.81 0.87 1.45

Competitive Comparison of Actelion's Cash Ratio

For the Biotechnology subindustry, Actelion's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Actelion's Cash Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actelion's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Actelion's Cash Ratio falls into.



Actelion Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Actelion's Cash Ratio for the fiscal year that ended in Dec. 2016 is calculated as:

Cash Ratio (A: Dec. 2016 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=485.953/558.122
=0.87

Actelion's Cash Ratio for the quarter that ended in Mar. 2017 is calculated as:

Cash Ratio (Q: Mar. 2017 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=758.638/522.392
=1.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Actelion  (OTCPK:ALIOF) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Actelion Cash Ratio Related Terms

Thank you for viewing the detailed overview of Actelion's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Actelion (Actelion) Business Description

Traded in Other Exchanges
N/A
Address
Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (Actelion) Headlines

From GuruFocus

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon 02-14-2017

Jean Hynes Reduces Stake in Actelion

By Kyle Ferguson Kyle Ferguson 08-03-2016

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon 01-24-2017

Actelion Still On Growth Track

By reports.droy reports.droy 02-18-2015